Advertisement
Advertisement

OCUL

OCUL logo

Ocular Therapeutix, Inc.

10.20
USD
Sponsored
-0.34
-3.27%
Jul 10, 15:42 UTC -4
Open

OCUL Earnings Reports

Positive Surprise Ratio

OCUL beat 19 of 42 last estimates.

45%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$13.46M
/
-$0.40
Implied change from Q1 26 (Revenue/ EPS)
+24.83%
/
--
Implied change from Q2 25 (Revenue/ EPS)
+0.03%
/
+2.56%

Ocular Therapeutix, Inc. earnings per share and revenue

On May 05, 2026, OCUL reported earnings of -0.40 USD per share (EPS) for Q1 26, missing the estimate of -0.31 USD, resulting in a -25.59% surprise. Revenue reached 10.79 million, compared to an expected 12.85 million, with a -16.08% difference. The market reacted with a -0.61% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 13.46 million USD, implying an increase of 0.00% EPS, and increase of 24.83% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cybin Inc. Common Stock
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.91
Actual
-$1.16
Surprise
-27.08%
FAQ
For Q1 2026, Ocular Therapeutix, Inc. reported EPS of -$0.40, missing estimates by -25.59%, and revenue of $10.79M, -16.08% below expectations.
The stock price moved down -0.61%, changed from $9.77 before the earnings release to $9.71 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 9 analysts, Ocular Therapeutix, Inc. is expected to report EPS of -$0.40 and revenue of $13.46M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement